Nutex Health (NUTX) Shares Outstanding (Weighted Average) (2010 - 2026)

Nutex Health has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $7.0 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $7.0 million, up 23.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (up 23.34% YoY), and the FY2025 annual result was $144620.0, down 30.25% from the prior year.
• Shares Outstanding (Weighted Average) came in at $7.0 million for Q1 2026 at Nutex Health, up from $144620.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $646.4 million in Q2 2022 to a low of $144620.0 in Q4 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $5.0 million (2024), against an average of $115.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 3091.98% in 2022 and tumbled 99.32% in 2023, its largest moves.
• Nutex Health's Shares Outstanding (Weighted Average) stood at $4.2 million in 2022, then gained by 4.15% to $4.4 million in 2023, then plunged by 95.3% to $207338.0 in 2024, then plunged by 30.25% to $144620.0 in 2025, then jumped by 4733.24% to $7.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $7.0 million (Q1 2026), $144620.0 (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.